Table 1 |
||||||
|
Prevalence of cytoplasmic, nucleoplasmic and NE antibodies by immunofluorescence using various substrates and fixation schemes in 33 PBC patients' sera. |
||||||
|
Cell type/fixation |
autoantigen localization |
|||||
|
|
||||||
|
Cytoplasmic |
nucleoplasmic |
NE |
||||
|
|
||||||
|
No. |
% |
No. |
% |
No. |
% |
|
|
|
||||||
|
HeLa/4%FA |
19 |
57.5 |
10 |
30.3 |
11 |
33.3 |
|
HeLa/1%FA |
9 |
27.2 |
12 |
36.4 |
13 |
39.4 |
|
Hep2/4%FA |
25 |
75.7 |
13 |
39.4 |
11 |
33.3 |
|
Hep2/1%FA |
10 |
30.3 |
15 |
45.4 |
15 |
45.4 |
|
Hep2 Inova |
18 |
54.5 |
13 |
39.4 |
5 |
15.1 |
|
Hep2 bmd |
19 |
57.5 |
12 |
36.4 |
4 |
12.1 |
|
Hep2 Zeus |
17 |
51.5 |
18 |
54.5 |
7 |
21.2 |
|
|
||||||
|
Tsiakalou et al. BMC Immunology 2006 7:20 doi:10.1186/1471-2172-7-20 |
||||||
